Randomized Trial Comparing Colesevelam vs. Ezetimibe

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT02682680

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02682680
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02682680. Randomized; no masking; primary purpose treatment. Start 2016-01-11 (actual); primary completion 2017-05-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial Comparing Colesevelam vs. Ezetimibe
Acronym
GOAL-RCT
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Colesevelam
Intervention (Drug)
Ezetimibe
Lead sponsor
LMC Diabetes & Endocrinology Ltd. (class: other)
Collaborator
Bausch Health Americas, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02682680
Content hash
3310211e0bea86f9a2b8c1b75f477b176ec6b236c9039289b6e1d3fa5246b297